Clinical Trial Update: A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. [Phase 1, Phase 2]

View source ↗

Summary

An early-phase (Phase 1/2) study of MIL116 is currently recruiting healthy participants and patients with Immunoglobulin A nephropathy to evaluate safety and pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• MIL116

Snippet

Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Immunoglobulin A Nephropathy | Phase 1, Phase 2 | Status: RECRUITING